DOCSLIB.ORG

2 Türk Psikiyatri Dergisi 2 Turkish Journal of Psychiatry

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2 Türk Psikiyatri Dergisi 2 Turkish Journal of Psychiatry 2 Türk Psikiyatri Dergisi 2 Turkish Journal of Psychiatry CİLT | Volume 26 GÜZ | Autumn 2015 EK | Supplement 2: 51. ULUSAL PSİKİYATRİ KONGRESİ TÜRKİYE SİNİR VE BİLDİRİ ÖZETLERİ RUH SAĞLIĞI ISSN 1300 – 2163 DERNEĞİ 2 Türk Psikiyatri Dergisi 2 Mart, Haziran, Eylül ve Aralık aylarında olmak üzere yılda 4 sayı çıkar Turkish Journal of Psychiatry Four issues annually: March, June, September, December CİLT | Volume 26 GÜZ | Autumn 2015 Türkiye Sinir ve Ruh Sağlığı Derneği EK | Supplement 2 tarafından yayınlanmaktadır. ISSN 1300 – 2163 www.turkpsikiyatri.com Türk Psikiyatri Dergisi Bu Sayının Yayın Yönetmeni /Editor in Chief of this Issue Doç. Dr. Semra Ulusoy Kaymak Türkiye Sinir ve Ruh Sağlığı Derneği adına Sahibi ve Sorumlu Müdürü Kongre Başkanları Published by Turkish Association of Nervous and Mental Health Prof. Dr. M. Orhan Öztürk Prof. Dr. Simavi Vahip - Prof. Dr. M. Murat Demet Düzenleme Kurulu Yayın Yönetmeni/ Editor in Chief Ömer Böke Prof. Dr. Aygün Ertuğrul M. Murat Demet E. Cüneyt Evren Yazışma Adresi / Corresponding Address Meram Can Saka PK 401, Yenişehir 06442 Ankara Selim Tümkaya Semra Ulusoy Yönetim Yeri / Editorial Office Simavi Vahip Kenedi Cad. 98/4, Kavaklıdere, Ankara Telefon: (0-312) 427 78 22 Bu Sayının Yayın Yönetmen Yardımcıları / Faks: (0-312) 427 78 02 Assoc. Editors in Chief of this Issue Selim Tümkaya Yayın Türü / Publication Category Yasin Duman Yaygın, Süreli, Bilimsel Yayın Aygün Yusifova Tuğçe Akçaer Reklam / Advertisements Reklam koşulları ve diğer ayrıntılar için yayın yönetmeniyle ilişkiye geçilmesi gerekmektedir. Yayın Hizmetleri / Publishing Services BAYT Bilimsel Araştırmalar Basın Yayın ve Tanıtım Ltd. Şti. (Dergide yer alan yazılarda belirtilen görüşlerden yazarlar sorumludur. Yazılardan kaynak göstererek alıntı yapılabilir.) Tel (0-312) 431 30 62, Faks: (0-312) 431 36 02 (Authors are responsible for the opinions reported in the articles. All rights reserved.) E-posta: [email protected] Grafik Tasarım / Graphic Design ∞ Mehmet Uluşahin Bu yayında ISO 9706: 1994 Uluslararası standartlarına uygun olarak asitsiz kağıt kullanılmıştır. This publication is printed on acid-free paper that meets the international standart ISO Baskı / Printing 9706: 1994 (Requirements for permanence) Miki Matbaacılık San. ve Tic. Ltd.Şti. Matbaacılar Sitesi 560. Sk., No:27, İvedik, Ankara Tel. (0-312) 395 21 28 Baskı Tarihi: Şubat 2016 Ağtasarımı ve Çevrimiçi Yayıncılık Hizmetleri Ada Yazılım Ltd. Şti. tarafından sağlanmaktadır. Türk Psikiyatri Dergisi’ne gelen bütün yazılar yazarların adları saklı tutularak bağımsız danışmanlarca değerlendirilir. All manuscripts submitted to the Turkish Journal of Psychiatry are assessed by independent referees anonymously. TÜRK PSİKİYATRİ DERGİSİ INDEX MEDICUS, TÜBİTAK TIP, PSYCHINFO, TÜRKİYE ATIF DİZİNİ ve SSCI DİZİNLERİNDEDİR. Turkish Journal of Psychiatry is indexed in INDEX MEDICUS, TUBITAK Medical Index, PSYCH-INFO, TURKIYE CITATION INDEX, and SSCI Ulusal Psikiyatri Kongresi 25 - 29 Kasım 2015 Susesi Hotel, Antalya Bilimin Işığında... TANI ve TEDAVİDE GÜNCEL GEREKSİNİMLER BİLDİRİ ÖZETLERİ A1 TÜRKİYE PSİKİYATRİ DERNEĞİ KURULLARI 2014-2016 YÖNETİM KURULU Merkez Yönetim Kurulu Simavi Vahip (Genel Başkan) Ahmet Tamer Aker (Genel Başkan Yardımcısı) Mehmet Yumru (Genel Sekreter) Meram Can Saka (Sayman) Şahut Duran (Örgütlenme Sekreteri) Murat Aktepe (Asistan Hekimlik Sekreteri) Ayşe Gül Yılmaz Özpolat (Eğitim Sekreteri) Merkez Denetleme Kurulu Sezai Berber Gamze Özçürümez Kazım Yazıcı Merkez Onur Kurulu Doğan Yeşilbursa Nevzat Yüksel Rukiye Peykan Gençoğlu Gökalp Hüseyin Soysal Haldun Soygür Yeterlik Yürütme Kurulu Eğitim Programları Geliştirme Altkurulu Akreditasyon Altkurulu Mustafa Sercan (Başkan) Ömer Böke (Başkan) Mustafa Sercan (Başkan) Serhat Çıtak (Başkan Yardımcısı) Ayşe Devrim Başterzi Numan Konuk Leyla Gülseren (Genel Sekreter) Feryal Çam Çelikel Serhat Çıtak Ömer Böke M. Hamid Boztaş Can Cimilli Ayşe Devrim Başterzi Ozan Pazvantoğlu Berna D. Uluğ Feryal Çam Çelikel Selime Çelik Sibel Örsel Aylin Ertekin Yazıcı Gamze Erzin Hüseyin Güleç Levet Atik Numan Konuk Yeterlik Sınav Altkurulu Yaygın ve Örgün Eğitim Kurulu Yayıncılık Kurulu Ayşe Devrim Başterzi (Başkan) Aylin Ertekin Yazıcı (Başkan) İ. Tolga Binbay (Başkan) Halis Ulaş Leyla Gülseren Ömer Aydemir Evrim Tellioğlu Levent Atik Adem Bayrakçı Cem Cerit E. Timuçin Oral Ömer Saatçioğlu Koray Başar Altan Eşsizoğlu Taner Yılmaz Medine Yazıcı Güleç Tuğba Özel Özlem Kuman Zerrin Oğlağu Deniz Ceylan Umut Mert Aksoy Necip Çapraz (AHK) Hamid Boztaş (EPGAK) A2 TÜRKİYE 2 Türk Psikiyatri Dergisi 2 SİNİR VE RUH SAĞLIĞI Turkish Journal of Psychiatry DERNEĞİ CİLT | Volume 26 GÜZ| Autumn 2015 İçindekiler | Contents EK | Supplement 2 51. ULUSAL PSİKİYATRİ KONGRESİ BİLDİRİ ÖZETLERİ A5 HOŞ GELDİNİZ M. Murat Demet TPD-BTDK Başkanı Simavi Vahip TPD Başkanı A6 KONGRE DÜZENLEME KURULLARI 1 ÖDÜLE ADAY ARAŞTIRMA BİLDİRİLERİ 11 SÖZEL BİLDİRİLER 39 POSTER BİLDİRİLER 139 YAZAR DİZİNİ A3 A4 TÜRKİYE 2 Türk Psikiyatri Dergisi 2 SİNİR VE RUH SAĞLIĞI Turkish Journal of Psychiatry DERNEĞİ CİLT | Volume 26 GÜZ| Autumn 2015 Hoş Geldiniz | Welcome EK | Supplement 2 51. ULUSAL PSİKİYATRİ KONGRESİ Değerli meslektaşlarımız, Türkiye Psikiyatri Derneği’nin düzenlediği 51. Ulusal Psikiyatri Kongresi bu yıl Antalya’da gerçekleştirilecektir. Her yıl oldu- ğu gibi bu yıl da Türkiye psikiyatri topluluğunun bu en büyük kongresinde zengin bir bilimsel program için hazırlıklarımız sürmektedir. Başta Çalışma Birimlerimiz olmak üzere tüm üyelerimizden, meslektaşlarımızdan ve ruh sağlığı çalışanlarından gelecek öneriler Bilimsel Toplantılar Düzenleme Kurulumuz tarafından harmanlanacak ve yine nitelikli ve zengin bir program ortaya çıkacaktır. Bu yılın kongre ana başlığı ve teması “Bilimin Işığında... Tanı ve Tedavide Güncel Gereksinimler” olarak belirlenmiştir. Bilimsel program, klinisyenlerin başta tanı ve tedavi olmak üzere pek çok alanda gereksinimlerini gözeten ana konferans, kurs, panel, çalışma grubu, münazara, on soruda bir konu, siz olsaydınız ne yapardınız, Sorular ve Olgularla Psikiyatride Güncel Oturumları gibi birçok farklı biçimde eğitim etkinlikleri ile dolu olacaktır. Elbette ülkemizde ruh sağlığı alanındaki sorunların konuşulacağı oturumlar ve yıl boyu gerçekleştirilen araştırma ürünlerinin sergileneceği ve tartışılacağı oturumlar da bizleri bek- liyor. Ve elbette ki tüm program için ödün vermeyeceğimiz, vazgeçemeyeceğimiz temel ilke “Bilimin Işığında…” olacaktır. Bu yıl ne yazık ki elimizde olmayan bir gelişme nedeniyle kongremizin bir süre önce duyurduğumuz tarihini değiştirmek zorunda kaldık. Kısa bir süre önce, kongreyi gerçekleştireceğimiz otelin de içinde yer aldığı bölgedeki birçok otel, Dışişleri Bakanlığı’nca G20 zirvesi ve sonrası etkinlikler gerekçe gösterilerek belirlediğimiz tarihler için bloke edilmiştir. Yoğun uğra- şılar sonucunda bu yılın Ulusal Psikiyatri Kongresi’ni 25-29 Kasım 2015 tarihlerine alabildik. Bu gelişme, bilimsel programı zenginleştirmek üzere bağlantı kurup konferans ve çeşitli eğitim etkinliklerinde yer almak üzere yurtdışından davet ettiğimiz birçok bilim insanının programlarında ciddi sorunlar yaratmıştır. Tüm bunlara karşın bilimsel programı yurtdışından bilim insanlarıyla destekleme çalışmalarımız sürmektedir. 51. Ulusal Psikiyatri Kongre’sinin, bir yandan zengin bilimsel programını izlerken bir yandan da yeni dostluklar, arkadaşlıklar kurup meslektaş bağları ve işbirlikleri geliştireceğimiz bir ortam olmasını umuyoruz. Bir yandan dünyadaki ve ülkemizdeki gelişmelerin alanımıza yansımalarını ele alırken bir yandan da ruh sağlığı alanında birlikte çalıştığımız diğer disiplinlerle ve tüm ruh sağlığı çalışanlarıyla yakınlaştığımız ve işbirliğine yönelik adımlar attığımız bir ortam olmasını diliyoruz. Ve elbette ki Kongremizin Türkiye psikiyatrisinin sesini gerek parlamentoya, hükümete ve tüm siyasi partilere gerekse tüm kamuoyuna güçlü bir şekilde duyurması için bir fırsat yaratmasını bekliyoruz. Tüm TPD üyelerini, meslektaşlarımızı ve ruh sağlığı çalışanlarını 51. Ulusal Psikiyatri Kongresi’ne davet ediyoruz. Özellikle Çalışma Birimlerimiz aracılığı ile gelecek yaratıcı ve programı zenginleştirici önerilerin önemini anımsatmak isteriz. Tüm üyelerimizi, tüm meslektaşlarımızı ve tüm ruh sağlığı çalışanlarını yılın bu en büyük ve bilimsel içeriği açısından en zengin kongresine katılmaya ve gerek uzmanlık eğitimine gerekse uzmanlık sonrası eğitime yönelik birçok gereksinimi karşı- layacak etkinliklere katılmaya davet ediyoruz. Türkiye Psikiyatri Derneği’nin düzenlediği 51. Ulusal Psikiyatri Kongre’sinde buluşmak dileğiyle… Prof. Dr. Simavi Vahip Prof. Dr. M. Murat Demet Türkiye Psikiyatri Derneği Türkiye Psikiyatri Derneği Genel Başkanı Bilimsel Toplantılar Düzenleme Kurulu Başkanı A5 51. ULUSAL PSİKİYATRİ KONGRESİ 25-29 Kasım, 2015 Susesi Hotel, Antalya, Türkiye KONGRE DÜZENLEME KURULLARI KONGRE EŞBAŞKANLARI / CONGRESS CO-PRESIDENTS 51. UPK ÖDÜL KURULU Simavi Vahip - M. Murat Demet Ayşegül Özerdem (Başkan) Kaan Kora (Üye) DÜZENLEME KURULU / ORGANISING COMMITTEE Şeref Gülseren (Üye) Ömer Böke M. Murat Demet ARAŞTIRMA BİLDİRİ ÖDÜLÜ SEÇİCİ KURUL ÜYELERİ E. Cüneyt Evren Behçet Coşar Meram Can Saka Şebnem Pırıldar Selim Tümkaya Vesile Şentürk Semra Ulusoy Doğan Yeşilbursa Simavi Vahip Olcay Yazıcı Timuçin Oral (Yedek Üye) BİLİMSEL TOPLANTILAR DÜZENLEME KURULU M. Murat Demet (Başkan) TPD ÇALIŞMA BİRİMİ KOORDİNATÖRLERİ E. Cüneyt Evren Asena Akdemir Osman Özdel Selim Tümkaya Erhan Akıncı Müjgan Özen Ömer Böke Umut Mert Aksoy İlker Özyıldırım Semra Ulusoy Tunç Alkın Yavuz Selvi Kürşat Altınbaş Bengi Semerci 2012-2014 BİLİMSEL
Load more

Recommended publications
  • What Are the Treatments for Heroin Addiction?
    How is heroin linked to prescription drug abuse? See page 3. from the director: Research Report Series Heroin is a highly addictive opioid drug, and its use has repercussions that extend far beyond the individual user. The medical and social consequences of drug use—such as hepatitis, HIV/AIDS, fetal effects, crime, violence, and disruptions in family, workplace, and educational environments—have a devastating impact on society and cost billions of dollars each year. Although heroin use in the general population is rather low, the numbers of people starting to use heroin have been steadily rising since 2007.1 This may be due in part to a shift from abuse of prescription pain relievers to heroin as a readily available, cheaper alternative2-5 and the misperception that highly pure heroin is safer than less pure forms because it does not need to be injected. Like many other chronic diseases, addiction can be treated. Medications HEROIN are available to treat heroin addiction while reducing drug cravings and withdrawal symptoms, improving the odds of achieving abstinence. There are now a variety of medications that can be tailored to a person’s recovery needs while taking into account co-occurring What is heroin and health conditions. Medication combined with behavioral therapy is particularly how is it used? effective, offering hope to individuals who suffer from addiction and for those around them. eroin is an illegal, highly addictive drug processed from morphine, a naturally occurring substance extracted from the seed pod of certain varieties The National Institute on Drug Abuse (NIDA) has developed this publication to Hof poppy plants.
    [Show full text]
  • Skin Manifestations of Illicit Drug Use Manifestações Cutâneas
    RevABDV81N4.qxd 12.08.06 13:10 Page 307 307 Educação Médica Continuada Manifestações cutâneas decorrentes do uso de drogas ilícitas Skin manifestations of illicit drug use Bernardo Gontijo 1 Flávia Vasques Bittencourt 2 Lívia Flávia Sebe Lourenço 3 Resumo: O uso e abuso de drogas ilícitas é um problema significativo e de abrangência mun- dial. A Organização das Nações Unidas estima que 5% da população mundial entre os 15 e 64 anos fazem uso de drogas pelo menos uma vez por ano (prevalência anual), sendo que meta- de destes usam regularmente, isto é, pelo menos uma vez por mês. Muitos dos eventos adver- sos das drogas ilícitas surgem na pele, o que torna fundamental que o dermatologista esteja familiarizado com essas alterações. Palavras-chave: Drogas ilícitas; Drogas ilícitas/história; Drogas ilícitas/efeitos adversos; Pele; Revisão Abstract: Illicit drug use and abuse is a major problem all over the world. The United Nations estimates that 5% of world population (aged 15-64 years) use illicit drugs at least once a year (annual prevalence) and half of them use drugs regularly, that is, at least once a month. Many adverse events of illicit drugs arise on the skin and therefore dermatologists should be aware of these changes. Keywords: Street drugs; Street drugs/history; Street drugs/adverse effects; Skin; Review HISTÓRICO Há mais de cinco mil anos na Mesopotâmia, minorar o sofrimento dos condenados. região onde hoje se situa o Iraque, os poderes cal- Provavelmente seja o ópio a droga nephente à qual mantes, soníferos e anestésicos do ópio (do latim Homero se referia como “o mais poderoso destrui- opium, através do grego opion, ‘seiva, suco’) já eram dor de mágoas”.1,2 conhecidos pelos sumérios.
    [Show full text]
  • Surveillance of Drug Abuse Trends in the State of Ohio January - June 2019
    OSAMOSAM OhioOhio Substance Substance Abuse Abuse Monitoring Monitoring Network Network SurveillanceSurveillance of of Drug Drug Abuse Abuse Trends Trends in the State of Ohio January - June 2019 Lake Ashtabula Fulton Lucas Williams Ottawa Geauga Cuyahoga Defiance Henry Wood Sandusky Erie Lorain Trumbull Huron Summit Portage Paulding Seneca Medina Putnam Hancock Mahoning Van Wert Wyandot Crawford Ashland Wayne Stark Columbiana Allen Richland Hardin Marion Mercer Auglaize Holmes Carroll Morrow Tuscarawas Jefferson Logan Knox Shelby Union Delaware Coshocton Harrison Champaign Darke Licking Miami Guernsey Belmont Franklin Muskingum Clark Madison Montgomery Preble Fairfield Perry Noble Monroe Greene Pickaway Fayette Morgan Hocking Washington Butler Warren Clinton Ross Athens Vinton Hamilton Highland Clermont Pike Meigs Jackson Brown Adams Scioto Gallia Lawrence Legend Akron-Canton region Columbus region Athens region Dayton region Cincinnati region Toledo region Cleveland region Youngstown region Ohio Substance Abuse Monitoring Network Surveillance of Drug Abuse Trends in the State of Ohio January - June 2019 Prepared by: Ohio Department of Mental Health and Addiction Services Office of Quality, Planning and Research R. Thomas Sherba, OSAM Principal Investigator — PhD, MPH, LPCC Sarah Balser, OSAM Coordinator — MPH, MSW, LSW, CHES Jessica Linley, OSAM Quantitative Data Analyst — PhD, MSW, LSW Table of Contents OSAM-O-Gram....................................................................................................................................................................3
    [Show full text]
  • Commonly Used Drugs
    Commonly Used Drugs Many drugs can alter a person’s thinking and judgment, and can lead to health risks, including addiction, drugged driving, infectious disease, and adverse effects on pregnancy. Information on commonly used drugs with the potential for misuse or addiction can be found here. For information about treatment options for substance use disorders, see NIDA’s Treatment pages. For drug use trends, see our Trends and Statistics page. For the most up-to-date slang terms, please see Slang Terms and Code Words: A Reference for Law Enforcement Personnel (DEA, PDF, 1MB). The following drugs are included in this resource: ➢ Alcohol ➢ Methamphetamine ➢ Ayahuasca ➢ Over-the-Counter Medicines--Dextromethorphan ➢ Central Nervous System Depressants (DXM) ➢ Cocaine ➢ Over-the-Counter Medicines--Loperamide ➢ DMT ➢ PCP ➢ GHB ➢ Prescription Opioids ➢ Hallucinogens ➢ Prescription Stimulants ➢ Heroin ➢ Psilocybin ➢ Inhalants ➢ Rohypnol® (Flunitrazepam) ➢ Ketamine ➢ Salvia ➢ Khat ➢ Steroids (Anabolic) ➢ Kratom ➢ Synthetic Cannabinoids ➢ LSD ➢ Synthetic Cathinones ("Bath Salts") ➢ Marijuana (Cannabis) ➢ Tobacco/Nicotine ➢ MDMA (Ecstasy/Molly) ➢ Mescaline (Peyote) **Drugs are classified into five distinct categories or schedules “depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential.” More information and the most up-to-date scheduling information can be found on the Drug Enforcement Administration’s website. June 2020 Alcohol People drink to socialize, celebrate, and relax. Alcohol often has a strong effect on people—and throughout history, people have struggled to understand and manage alcohol’s power. Why does alcohol cause people to act and feel differently? How much is too much? Why do some people become addicted while others do not? The National Institute on Alcohol Abuse and Alcoholism is researching the answers to these and many other questions about alcohol.
    [Show full text]
  • Minutes Health & Human Services Board Meeting
    MINUTES HEALTH & HUMAN SERVICES BOARD MEETING ROOM #1, OUTAGAMIE COUNTY ADMINISTRATION BUILDING TUESDAY, DECEMBER 13, 2016 MEMBERS PRESENT: Patrick Meyer, Vice-Chairperson; Dan Gabrielson, Secretary; *Justin Krueger; Richard Gosse; Jerry Iverson; Christine Lamers; Keith Suprise; and Cathy Thompson MEMBERS EXCUSED: Barney Lemanski, Chairperson; and Veronica Flower OTHERS PRESENT: Rosemary Davis, Director; John Rathman, Deputy Director; *Morgan Hinkley, Brewster Village Administrator; *Megan Vandehey, Brewster Village Student Intern; *Brad Dunlap, Department of Criminal Investigations, Narcotics Bureau; *Chris Wardlow, Substance Abuse Prevention Specialist; Mary Dorn, Public Health Officer/Manager; *Brian Bezier, Clinical Director/Manager of MH/AODA; and Linda Rasmussen, Management Assistant *Attended a portion of the meeting. Patrick Meyer called the meeting to order at 4:45 p.m. APPROVAL OF MINUTES: MOTION – Keith Suprise moved approval of the November 8, 2016 minutes. Seconded by Dan Gabrielson. (7 ayes, 0 nays, 1 abstention) Motion carried. PUBLIC COMMENT ON AGENDA ITEMS: None BREWSTER VILLAGE UPDATE AND TABLE OF ORGANIZATION CHANGE: Morgan Hinkley indicated that Brewster Village currently has 2 Administrative Secretaries sharing one full-time position, each working every other week. They are both retiring, which provided an opportunity to evaluate the structure of the position. Various back-up options were looked at, since the two functioned as each other’s back-ups. Additional staff were trained in various duties and discussion was held whether the position could be part time; however, in reviewing a time study and evaluating all of the tasks and how much time is spent on each of those, it was determined that there is a need for the position to be filled in a full-time capacity.
    [Show full text]
  • Date: 1/9/2017 Question: Botulism Is an Uncommon Disorder Caused By
    6728 Old McLean Village Drive, McLean, VA 22101 Tel: 571.488.6000 Fax: 703.556.8729 www.clintox.org Date: 1/9/2017 Question: Botulism is an uncommon disorder caused by toxins produced by Clostridium botulinum. Seven subtypes of botulinum toxin exist (subtypes A, B, C, D, E, F and G). Which subtypes have been noted to cause human disease and which ones have been reported to cause infant botulism specifically in the United States? Answer: According to the cited reference “Only subtypes A, B, E and F cause disease in humans, and almost all cases of infant botulism in the United States are caused by subtypes A and B. Botulinum-like toxins E and F are produced by Clostridium baratii and Clostridium butyricum and are only rarely implicated in infant botulism” (Rosow RK and Strober JB. Infant botulism: Review and clinical update. 2015 Pediatr Neurol 52: 487-492) Date: 1/10/2017 Question: A variety of clinical forms of botulism have been recognized. These include wound botulism, food borne botulism, and infant botulism. What is the most common form of botulism reported in the United States? Answer: According to the cited reference, “In the United States, infant botulism is by far the most common form [of botulism], constituting approximately 65% of reported botulism cases per year. Outside the United States, infant botulism is less common.” (Rosow RK and Strober JB. Infant botulism: Review and clinical update. 2015 Pediatr Neurol 52: 487-492) Date: 1/11/2017 Question: Which foodborne pathogen accounts for approximately 20 percent of bacterial meningitis in individuals older than 60 years of age and has been associated with unpasteurized milk and soft cheese ingestion? Answer: According to the cited reference, “Listeria monocytogenes, a gram-positive rod, is a foodborne pathogen with a tropism for the central nervous system.
    [Show full text]
  • MF3404 the Opioid Crisis: What You Need to Know
    The Opioid Crisis: What You Need to Know The opioid crisis has swept across the nation at an Key Facts alarming rate. Drug abuse, dependence, and overdose are • Opioids are a class of drugs that include powerful issues that affect the lives of millions of Americans. Given prescription pain relievers — such as oxycodone, codeine, the severity of the opioid crisis in the United States, action morphine, and fentanyl — and the illegal drug heroin. must be taken at multiple levels to stop the devastating • Opioids work by binding to opioid receptors in your body consequences. One of those steps is education. This fact to relieve pain. sheet will discuss: • Prescription opioids can be an important part of treatment • what opioids are, but carry significant risks for addiction and overdose • which opioids are most commonly abused and why, because of the addictive euphoria they create and the tolerance that occurs after repetitive dosing. • the risks associated with abusing opioids and who is • Drug overdose is the leading cause of accidental death most vulnerable to an opioid addiction, in the United States, of which a large majority is due to • the signs of an opioid addiction and overdose, prescription and illegal opioids. Seven drug related deaths occur every hour in the United States. • how to respond to an opioid overdose, • There are effective treatment options for opioid • how to safely store and dispose of opioid medications, dependence, yet only 10 percent of people who need such and treatment are receiving it. • steps individuals and communities can take to address • Naloxone, also called Narcan® or Evzio®, can completely the opioid crisis.
    [Show full text]
  • Save a Life – Opioid Awareness What Are Opioids?
    Save A Life – Opioid Awareness What Are Opioids? Opioids are a class of pain-relieving drugs that work by interacting with opioid receptors in your cells. Opioids are made from the poppy plant or produced in a laboratory. Prescription opioids include: • Codeine Dilaudid • Fentanyl Heroin • Hydrocodone Methadone • Morphine Oxycodone • Oxycontin® a/k/a "Oxy" Percocet® a/k/a "Percs" • Tramadol Vicodin® a/k/a "Vikes" 50% of those who take prescription opioids without a prescription get them for free from a friend or relative, according to the Substance Abuse and Mental Health Services Administration (SAMHSA) What is Fentanyl? Fentanyl is a powerful synthetic opioid (80 times more potent than morphine) that since 2013 has driven the steep rise in opioid overdoses. • It is a synthetic (made by chemicals) opioid (DEA) • It is roughly 100 times more potent than morphine (DEA) • It is about 50 times more potent than heroin (DEA) • It is a pharmaceutical drug used to treat patients with severe pain (NIH) • It is now produced in illegal drug factories and sold to drug dealers who package it in stash houses and clandestine labs • It is responsible for more fatal overdoses than heroin and prescription pain pills (CDC) • Drug dealers are producing counterfeit pills that look almost identical to legitimate prescription opioids and filling them with fentanyl (DEA) What is Heroin? Heroin is in the opioid class of drugs. It is a very addictive drug made from morphine, a psychoactive (mind- altering) substance. Heroin’s color and look depend on how it is made and what else it may be mixed with.
    [Show full text]
  • Surveillance of Drug Abuse Trends in the State of Ohio (OSAM)
    OSAM Ohio Substance Abuse Monitoring Network Surveillance of Drug Abuse Trends in the State of Ohio June 2014 - January 2015 Legend Akron-Canton region Columbus region Athens region Dayton region Cincinnati region Toledo region Ohio Department of Mental Health and Addiction Services Cleveland region Youngstown region Office of Quality, Planning and Research Ohio Substance Abuse Monitoring Network Surveillance of Drug Abuse Trends in the State of Ohio June 2014 - January 2015 Prepared by: Ohio Department of Mental Health and Addiction Services Office of Quality, Planning and Research Sanford Starr, Deputy Director — MSW, LISW-S R. Thomas Sherba, OSAM Principal Investigator — PhD, MPH, LPCC Beth E. Gersper, OSAM Coordinator — MPA Table of Contents OSAM-O-Gram ...........................................................................................................................................................3 Executive Summary ...................................................................................................................................................5 Drug Abuse Trends by Region Akron-Canton Region ............................................................................................................................................ 21 Athens Region .......................................................................................................................................................... 39 Cincinnati Region ...................................................................................................................................................
    [Show full text]
  • National Trends in Drug Abuse
    If you have issues viewing or accessing this file contact us at NCJRS.gov. Ef~t}! OFFICE OF NATIONAL DR UG CONTROL POLICY PULSE CHECK National Trends in Drug Abuse Executive Office of the President Office of National Drug Control Policy Barry R. McCaffrey, Director Office of Programs, Budget, Research, and Evaluation Released Winter 1997 Highlights The Pulse Check is a report on the use and distribution of illicit drugs in various areas of the country that is published semi-annually by the Office of National Drug Control Policy (ONDCP). It is based on conversations with drug researchers (i.e., ethnographers, epidemiologists), law enforcement officials (i.e, State police, DEA agents) and substance abuse treatment providers nationwide. Highlights of the current issue are summarized below. Heroin drug users unlike typical heroin dealers who distribute through a network of acquaintances. • The increased popularity of heroin has While they combine distribution of heroin and reached most regions of the country. High cocaine, they usually do not sell marijuana, purity heroin is widely available in the urban hallucinogens, methamphetamine or any other areas of the Northeast, Mid-Atlantic and West. drugs. While it is less common in the South, its use is rising in that region also. Cocaine • Sources in all areas report the appearance of • Crack use is stable though it remains the more new, young users, although the majority dominant drug in most markets. Crack users of heroin users are still older, established users. are an older cohort than they were in the early Young users are likely to initiate heroin use by 1990s, indicating fewer initiates.
    [Show full text]
  • Heroin, Meth, and Poly-Substance Abuse: Where We Are Now
    Heroin, Meth, and Poly-Substance Abuse: Where We Are Now Jane C. Maxwell, Ph.D. Research Professor The University of Texas at Austin No Relevant Financial Conflicts: Relevant to the content of this educational activity, I do not have any relevant financial conflicts with commercial interest companies to disclose. Heroin Overdose Deaths: 2017 CDC Wonder & Kaiser Family Foundation Synthetic Opioid Deaths (fentanyl, tramadol) CDC Wonder & Kaiser Family Foundation Opioid Overdoses Natural and Semisynthetic (oxycodone, hydrocodone): 2017 CDC Wonder & Kaiser Family Foundation Number of Drug Overdose Deaths Involving Opioids and Other Drug Types, Iowa Vital Statistics, 2010-2017 250 Other Opiates* Methamphetamine Heroin Cocaine 200 Other Opiates* 150 100 Methamphetamine Heroin 50 Cocaine 0 2010 2011 2012 2013 2014 2015 2016 2017 *Includes oxycodone, hydrocodone, synthetic narcotics (fentanyl) and other narcotics Mexican Black Tar Heroin SWA Brown Heroin or “Cheese” Heroin South American Heroin or “new” Mexican White Heroin Black Tar Heroin and Packaging Heroin Sources and Supply Routes 100 10 20 30 40 50 60 70 80 90 0 1977 1978 1979 1980 ( 1981 Distribution Area Source Heroin 1982 TRANSITION IN HEROIN SOURCE AREAS SOURCE IN HEROIN TRANSITION 1983 1984 1985 1986 Source:Heroin DEA Signature Program 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 1977 2008 2009 2010 2011 - 2012 2016) 2013 2014 2015 2016 Mexico Asia Southeast Asia Southwest America South Inconclusive Top Drugs Seized and Identified in Iowa • July-Oct, 2019., 48% of all drugs seized were meth, 28% cannabis, 7% cocaine, 3% fentanyl 2.4% heroin.
    [Show full text]
  • State of Texas Drug Use Patterns and Trends, 2019
    State of Texas Drug Use Patterns and Trends, 2019 Jane Carlisle Maxwell, Ph.D. Addiction Research Institute Highlights • Methamphetamine is the top drug threat reported by the three DEA Field Divisions that cover Texas. • Methamphetamine and cocaine problems continue to increase, with no FDA-approved Medication Assisted Treatment (MAT) available • The Texas Prescription Monitoring Program (PMP) and overdose prevention programs have led to decreases in the number of other opiate, synthetic narcotic, and benzodiazepine drugs prescribed. The Texas PMP was moved from the state law enforcement agency to the pharmacy board in 2016. • Heroin indicators are mixed. Since fentanyl cannot be easily mixed with gummy black tar heroin, the combination has not resulted in the number of deaths with heroin and fentanyl as in the Northeast. Fentanyl remains a concern about deaths involving other drugs, including speedballs. The number of tramadol pills identified in toxicological laboratories continue to rise. • In the past, cannabis indicators had involved monitoring the quantity and quality of the drug imported from Mexico. Now, cannabis indicators focus on effects of CBD oils, edibles, and other products brought in from states where they are legal. • The State’s response to the opioid epidemic has resulted in additional outreach and training to prevent overdoses, but changes in use patterns will require monitoring. Of the drugs used in Medication Assisted Treatment in Texas, the amount of methadone dosage per 100,000 used has dropped while the amount of buprenorphine has increased, although there is increased need for MAT. 1 Introduction Texas in 2018 has 254 counties and a population of 28,304,596, with 42% White, 39% Hispanic, and 13% Black.
    [Show full text]